vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Terreno Realty Corp（TRNO）财务数据对比。点击上方公司名可切换其他公司
Terreno Realty Corp的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍（$137.5M vs $75.5M），Terreno Realty Corp同比增速更快（32.6% vs 27.7%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 27.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Terreno Realty Corp是一家上市房地产投资信托公司，专注于持有、运营及收购优质工业地产资产，旗下资产组合主要包括位于美国高需求沿海都会区的配送仓库与物流设施，服务电商、最后一公里配送、零售供应链等领域的租户。
PBYI vs TRNO — 直观对比
营收规模更大
TRNO
是对方的1.8倍
$75.5M
营收增速更快
TRNO
高出4.8%
27.7%
两年增速更快
PBYI
近两年复合增速
27.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $137.5M |
| 净利润 | — | $158.2M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | — |
| 净利率 | — | 115.1% |
| 营收同比 | 27.7% | 32.6% |
| 净利润同比 | — | 107.9% |
| 每股收益（稀释后） | $0.26 | $1.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITRNO
| Q4 25 | $75.5M | $137.5M | ||
| Q3 25 | $54.5M | $116.2M | ||
| Q2 25 | $52.4M | $112.2M | ||
| Q1 25 | $46.0M | $110.4M | ||
| Q4 24 | $59.1M | $103.7M | ||
| Q3 24 | $80.5M | $99.6M | ||
| Q2 24 | $47.1M | $94.2M | ||
| Q1 24 | $43.8M | $85.0M |
净利润PBYITRNO
| Q4 25 | — | $158.2M | ||
| Q3 25 | $8.8M | $103.4M | ||
| Q2 25 | $5.9M | $93.3M | ||
| Q1 25 | $3.0M | $48.1M | ||
| Q4 24 | — | $76.1M | ||
| Q3 24 | $20.3M | $36.6M | ||
| Q2 24 | $-4.5M | $35.7M | ||
| Q1 24 | $-4.8M | $36.1M |
毛利率PBYITRNO
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYITRNO
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — | ||
| Q1 24 | -5.3% | — |
净利率PBYITRNO
| Q4 25 | — | 115.1% | ||
| Q3 25 | 16.2% | 88.9% | ||
| Q2 25 | 11.2% | 83.1% | ||
| Q1 25 | 6.5% | 43.6% | ||
| Q4 24 | — | 73.4% | ||
| Q3 24 | 25.2% | 36.8% | ||
| Q2 24 | -9.6% | 37.9% | ||
| Q1 24 | -11.0% | 42.4% |
每股收益（稀释后）PBYITRNO
| Q4 25 | $0.26 | $1.54 | ||
| Q3 25 | $0.17 | $1.00 | ||
| Q2 25 | $0.12 | $0.90 | ||
| Q1 25 | $0.06 | $0.47 | ||
| Q4 24 | $0.40 | $0.78 | ||
| Q3 24 | $0.41 | $0.37 | ||
| Q2 24 | $-0.09 | $0.37 | ||
| Q1 24 | $-0.10 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $25.0M |
| 总债务越低越好 | $22.7M | $943.3M |
| 股东权益账面价值 | $130.3M | $4.1B |
| 总资产 | $216.3M | $5.4B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资PBYITRNO
| Q4 25 | $97.5M | $25.0M | ||
| Q3 25 | $94.4M | $26.2M | ||
| Q2 25 | $96.0M | $128.4M | ||
| Q1 25 | $93.2M | $156.5M | ||
| Q4 24 | $101.0M | $18.1M | ||
| Q3 24 | $96.7M | $243.7M | ||
| Q2 24 | $96.8M | $182.0M | ||
| Q1 24 | $107.2M | $649.6M |
总债务PBYITRNO
| Q4 25 | $22.7M | $943.3M | ||
| Q3 25 | $34.0M | $1.0B | ||
| Q2 25 | $45.3M | $742.4M | ||
| Q1 25 | $56.7M | $741.9M | ||
| Q4 24 | $68.0M | $823.4M | ||
| Q3 24 | $79.3M | $672.2M | ||
| Q2 24 | $90.7M | $772.0M | ||
| Q1 24 | $102.0M | $771.8M |
股东权益PBYITRNO
| Q4 25 | $130.3M | $4.1B | ||
| Q3 25 | $115.3M | $4.0B | ||
| Q2 25 | $104.7M | $3.9B | ||
| Q1 25 | $97.1M | $3.9B | ||
| Q4 24 | $92.1M | $3.7B | ||
| Q3 24 | $71.1M | $3.6B | ||
| Q2 24 | $48.5M | $3.4B | ||
| Q1 24 | $51.0M | $3.4B |
总资产PBYITRNO
| Q4 25 | $216.3M | $5.4B | ||
| Q3 25 | $202.9M | $5.3B | ||
| Q2 25 | $194.9M | $5.0B | ||
| Q1 25 | $196.2M | $4.9B | ||
| Q4 24 | $213.3M | $4.8B | ||
| Q3 24 | $220.7M | $4.6B | ||
| Q2 24 | $205.0M | $4.5B | ||
| Q1 24 | $214.1M | $4.4B |
负债/权益比PBYITRNO
| Q4 25 | 0.17× | 0.23× | ||
| Q3 25 | 0.30× | 0.26× | ||
| Q2 25 | 0.43× | 0.19× | ||
| Q1 25 | 0.58× | 0.19× | ||
| Q4 24 | 0.74× | 0.22× | ||
| Q3 24 | 1.12× | 0.19× | ||
| Q2 24 | 1.87× | 0.22× | ||
| Q1 24 | 2.00× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $271.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 1.72× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYITRNO
| Q4 25 | $14.4M | $271.9M | ||
| Q3 25 | $9.7M | $79.5M | ||
| Q2 25 | $14.1M | $60.6M | ||
| Q1 25 | $3.6M | $61.4M | ||
| Q4 24 | $15.6M | $232.7M | ||
| Q3 24 | $11.0M | $70.0M | ||
| Q2 24 | $1.0M | $64.3M | ||
| Q1 24 | $11.2M | $47.0M |
自由现金流PBYITRNO
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYITRNO
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYITRNO
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYITRNO
| Q4 25 | — | 1.72× | ||
| Q3 25 | 1.10× | 0.77× | ||
| Q2 25 | 2.41× | 0.65× | ||
| Q1 25 | 1.21× | 1.28× | ||
| Q4 24 | — | 3.06× | ||
| Q3 24 | 0.54× | 1.91× | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | — | 1.30× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
TRNO
| Disposal Group Disposed Of By Sale Not Discontinued Operations | $109.5M | 80% |
| Other | $23.8M | 17% |
| At Market Equity Offering Program500Million | $4.1M | 3% |
